Home
/ MaxQ-AI
/ Competitors

MaxQ-AI Competitors and Similar CompaniesClear all

MaxQ-AI's competitors and similar companies include BOCAhealth, Transasia Bio-Medicals, Autobio Diagnostics and Zhejiang Orient Gene Biotech.

	MaxQ-AI MaxQ-AI develops software that uses artificial intelligence to interpret medical images, such as CT scans, and surrounding patient data.	BOCAhealth BOCAhealth is a body fluid management company.	Transasia Bio-Medicals Transasia Bio-Medicals is a developer and manufacturer of healthcare products.	Autobio Diagnostics Autobio Diagnostics (奧託生物診斷有限公司) is a manufacturer and supplier of medical diagnostics products.	Zhejiang Orient Gene Biotech Zhejiang Orient Gene Biotech (浙江东方基因生物制品股份有限公司) is a company that manufactures and sells vitro diagnostic products,
Founding Date	Founding Date 2013	Founding Date 2018	Founding Date 1979	Founding Date 1998	Founding Date 2005
Type	Type Private	Type Private	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare artificial intelligence medical devices medical diagnostics	Tags Healthcare artificial intelligence medical devices medical diagnostics medtech	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics
Locations	Locations Andover, US HQ Tel Aviv Yafo, IL	Locations Berlin, DE HQ	Locations HQ	Locations Zheng Zhou Shi, CN HQ	Locations Huzhou, CN HQ
Employees	Employees 428% increase	Employees 6	Employees 2,0351% increase	Employees 5,773	Employees 2,231
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 3.6 b	Valuation ($) 945.9 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥4.1b (FY, 2025)	Revenue (est.) ¥910.7m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥1.5b (FY, 2025)	Cost of goods ¥560.9m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ¥2.7b (FY, 2025)	Gross profit ¥366.6m (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income ¥1.1b (FY, 2025)	Net income (¥597.4m) (FY, 2025)